$66.230
+2.649 (+4.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PCVX por análisis de gráficos similares
Alphio's PCVX stock price prediction model matches the current Vaxcyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $62.62 (-0.96%). The 1-week path is $64.39 (+1.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vaxcyte Inc?
Vaxcyte Inc is a good buy right now, trading at $63.62 with a recent surge of over 60% following successful vaccine trial results. The RSI is currently at 43.406, indicating potential for upward momentum as it approaches oversold territory. The forward P/E ratio is at 0, suggesting that the stock is undervalued given its growth potential in the $3 billion to $6 billion adult pneumococcal vaccine market. However, the company is facing significant losses, with a projected net income loss of $320 million in Q1 2026, which is a primary risk to consider.
PCVX cerró en $66.23 el Tuesday, tras subir +4.00%
Vaxcyte Inc (PCVX) last closed at $63.23, losing -4.53%. These facts feed the 1-day and 1-week PCVX price prediction above.
Factores de la previsión
Los factores de la previsión de Vaxcyte Inc (PCVX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PCVX, ordenadas por similitud.
Análisis de estacionalidad de PCVX
Historically the probability of a positive October return for PCVX is 62.30%. February offers the highest probability of a positive month at 86.21%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PCVX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $27.34 | $32.32 | $36.02 | -48.89% |
| Nov 2026 | $37.97 | $42.65 | $49.56 | -32.55% |
| Dec 2026 | $39.67 | $40.50 | $43.09 | -35.94% |
En 2026, se proyecta que Vaxcyte Inc (PCVX) oscile entre $27.34 y $49.56.
Previsión mensual de Vaxcyte Inc para 2026
En Oct de 2026, se proyecta que Vaxcyte Inc promedie $32.32, con un mínimo de $27.34 y un máximo de $36.02.
En Nov de 2026, se proyecta que Vaxcyte Inc promedie $42.65, con un mínimo de $37.97 y un máximo de $49.56.
En Dec de 2026, se proyecta que Vaxcyte Inc promedie $40.50, con un mínimo de $39.67 y un máximo de $43.09.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.